175 related articles for article (PubMed ID: 20841521)
1. Stress ulcer prophylaxis: reducing non-indicated prescribing after hospital discharge.
Hatch JB; Schulz L; Fish JT
Ann Pharmacother; 2010 Oct; 44(10):1565-71. PubMed ID: 20841521
[TBL] [Abstract][Full Text] [Related]
2. Medication reconciliation effect on prolonged inpatient stress ulcer prophylaxis.
Zeigler AJ; McAllen KJ; Slot MG; Barletta JF
Ann Pharmacother; 2008 Jul; 42(7):940-6. PubMed ID: 18577762
[TBL] [Abstract][Full Text] [Related]
3. Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency.
Mousavi M; Dashti-Khavidaki S; Khalili H; Farshchi A; Gatmiri M
Int J Pharm Pract; 2013 Aug; 21(4):263-9. PubMed ID: 23418812
[TBL] [Abstract][Full Text] [Related]
4. Inappropriate continuation of stress ulcer prophylactic therapy after discharge.
Wohlt PD; Hansen LA; Fish JT
Ann Pharmacother; 2007 Oct; 41(10):1611-6. PubMed ID: 17848420
[TBL] [Abstract][Full Text] [Related]
5. Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting.
Farley KJ; Barned KL; Crozier TM
Crit Care Resusc; 2013 Jun; 15(2):147-51. PubMed ID: 23961576
[TBL] [Abstract][Full Text] [Related]
6. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
[TBL] [Abstract][Full Text] [Related]
7. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients.
Heidelbaugh JJ; Inadomi JM
Am J Gastroenterol; 2006 Oct; 101(10):2200-5. PubMed ID: 16952283
[TBL] [Abstract][Full Text] [Related]
8. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.
Murphy CE; Stevens AM; Ferrentino N; Crookes BA; Hebert JC; Freiburg CB; Rebuck JA
Pharmacotherapy; 2008 Aug; 28(8):968-76. PubMed ID: 18657013
[TBL] [Abstract][Full Text] [Related]
9. Overuse of stress ulcer prophylaxis in the critical care setting and beyond.
Farrell CP; Mercogliano G; Kuntz CL
J Crit Care; 2010 Jun; 25(2):214-20. PubMed ID: 19683892
[TBL] [Abstract][Full Text] [Related]
10. Impact of A Collaborative Strategy to Reduce the Inappropriate Use of Acid Suppressive Therapy in Non-Intensive Care Unit Patients.
Belfield KD; Kuyumjian AG; Teran R; Amadi M; Blatt M; Bicking K
Ann Pharmacother; 2017 Jul; 51(7):577-583. PubMed ID: 28622739
[TBL] [Abstract][Full Text] [Related]
11. Stress ulcer prophylaxis for non-critically ill patients on a teaching service.
Hwang KO; Kolarov S; Cheng L; Griffith RA
J Eval Clin Pract; 2007 Oct; 13(5):716-21. PubMed ID: 17824863
[TBL] [Abstract][Full Text] [Related]
12. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
[TBL] [Abstract][Full Text] [Related]
13. Effects of pharmacy resident led education on resident physician prescribing habits associated with stress ulcer prophylaxis in non-intensive care unit patients.
Agee C; Coulter L; Hudson J
Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S48-52. PubMed ID: 25991596
[TBL] [Abstract][Full Text] [Related]
14. Impact of stress ulcer prophylaxis algorithm study.
Coursol CJ; Sanzari SE
Ann Pharmacother; 2005 May; 39(5):810-6. PubMed ID: 15811900
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic benefits of de-escalating stress ulcer prophylaxis therapy in the intensive care unit: A quality improvement study.
Anstey MH; Litton E; Palmer RN; Neppalli S; Tan BJ; Hawkins DJ; Krishnamurthy RB; Jacques A; Sonawane RV; Chapman AR; Norman R
Anaesth Intensive Care; 2019 Nov; 47(6):503-509. PubMed ID: 31594383
[No Abstract] [Full Text] [Related]
16. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center.
Erstad BL; Camamo JM; Miller MJ; Webber AM; Fortune J
Crit Care Med; 1997 Oct; 25(10):1678-84. PubMed ID: 9377882
[TBL] [Abstract][Full Text] [Related]
17. Incidence and cost of stress ulcer prophylaxis after discharge from the intensive care unit: a retrospective study.
Tan B; Norman R; Litton E; Heath C; Hawkins DJ; Krishnamurthy R; Sonawane R; Anstey MH
Crit Care Resusc; 2016 Dec; 18(4):270-274. PubMed ID: 27903209
[TBL] [Abstract][Full Text] [Related]
18. Variables associated with stress ulcer prophylaxis misuse: a retrospective analysis.
Issa IA; Soubra O; Nakkash H; Soubra L
Dig Dis Sci; 2012 Oct; 57(10):2633-41. PubMed ID: 22427129
[TBL] [Abstract][Full Text] [Related]
19. Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.
Bez C; Perrottet N; Zingg T; Leung Ki EL; Demartines N; Pannatier A
J Eval Clin Pract; 2013 Apr; 19(2):374-8. PubMed ID: 22420909
[TBL] [Abstract][Full Text] [Related]
20. The economic benefit of practice guidelines for stress ulcer prophylaxis.
Mostafa G; Sing RF; Matthews BD; Pratt BL; Norton HJ; Heniford BT
Am Surg; 2002 Feb; 68(2):146-50. PubMed ID: 11842960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
